KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

NovoCure (NVCR) Receivables - Other (2022 - 2025)

NovoCure's Receivables - Other history spans 4 years, with the latest figure at $7.8 million for Q4 2025.

  • For Q4 2025, Receivables - Other rose 36.02% year-over-year to $7.8 million; the TTM value through Dec 2025 reached $7.8 million, up 36.02%, while the annual FY2025 figure was $7.8 million, 36.02% up from the prior year.
  • Receivables - Other for Q4 2025 was $7.8 million at NovoCure, up from $7.2 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $7.8 million in Q4 2025 and bottomed at $2.2 million in Q4 2022.
  • The 4-year median for Receivables - Other is $5.7 million (2024), against an average of $5.6 million.
  • The largest annual shift saw Receivables - Other skyrocketed 93.93% in 2023 before it increased 26.15% in 2025.
  • A 4-year view of Receivables - Other shows it stood at $2.2 million in 2022, then soared by 93.93% to $4.3 million in 2023, then soared by 34.67% to $5.7 million in 2024, then surged by 36.02% to $7.8 million in 2025.
  • Per Business Quant, the three most recent readings for NVCR's Receivables - Other are $7.8 million (Q4 2025), $7.2 million (Q3 2025), and $6.9 million (Q2 2025).